Polymer-Iron Oxide Nanostructure for Magnetic Field Reactivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional iron oxide nanoparticles have weak magnetic field reactivity, limiting their application in drug delivery and bioimaging systems, and existing methods struggle to selectively regulate gene expression without disrupting other cellular processes.
Innovation Solution
A polymer-iron oxide composite nanostructure with a silica coating layer is developed, allowing for precise control of iron oxide nanoparticle capture and magnetic field reactivity, and the attachment of DNA to inhibit gene expression by physical shielding in a magnetic field.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional iron oxide nanoparticles are used, then they exhibit superparamagnetism and biocompatibility, but they have weak magnetic field reactivity limiting drug delivery and bioimaging applications
Solution Approach 1:
The patent combines multiple iron oxide nanoparticles into a cluster structure, merging their magnetic moments to achieve strong magnetic field reactivity. This cluster approach allows the system to maintain superparamagnetism while exhibiting enhanced magnetic response for effective drug delivery and bioimaging applications.
Solution Approach 2:
The invention creates a composite structure with iron oxide nanoparticle clusters integrated into a polymer matrix. This composite material approach enables the system to simultaneously achieve magnetic field reactivity, biocompatibility, and controllable release properties for versatile biomedical applications.
2Manufacturing precision
If iron oxide nanoparticle clusters are synthesized using coagulation, then regular and uniform clusters are obtained, but the reactivity to magnetic field cannot be controlled by adjusting the number or ratio of nanoparticles
Solution Approach 1:
The patent introduces a dynamic control mechanism where the polymer matrix can be adjusted to control the number and arrangement of iron oxide nanoparticles within the cluster. This allows the magnetic field reactivity to be tuned by adjusting polymer properties such as molecular weight and composition while maintaining uniform cluster structure.
Solution Approach 2:
The invention enables control of magnetic field reactivity by changing polymer parameters including molecular weight, composition ratio, and synthesis conditions. These parameter adjustments allow precise control over the number of nanoparticles per cluster and their spatial arrangement, thereby tuning magnetic properties while maintaining structural uniformity.
3Measurement precision
If substances are used to bind to enzymes or genomes to regulate gene expression, then transcription or translation can be inhibited, but non-specific binding occurs causing unexpected disturbances in cellular processes
Solution Approach 1:
The patent applies local quality by designing polymer-iron oxide complexes with specific surface properties that selectively interact with target genes. The polymer structure is optimized to provide specific binding sites that recognize particular DNA sequences or chromatin structures, enabling selective gene regulation without non-specific binding to other cellular components.
Solution Approach 2:
The polymer-iron oxide complex acts as an intermediary between the magnetic field and the gene expression machinery. When exposed to a magnetic field, the complex locally concentrates at the target gene location and facilitates specific interactions with transcription factors or chromatin, providing controlled and specific gene regulation without direct toxic effects on cellular processes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polymer-iron oxide composite nanostructure enhances drug delivery and bioimaging capabilities by improving magnetic field reactivity and allows for selective regulation of gene expression, reducing protein production by inhibiting RNA polymerase binding to DNA, thereby minimizing disruption to other gene expression mechanisms.
Implementation Method 1
the polymer-iron oxide composite nanostructure enhances drug delivery and bioimaging capabilities by improving magnetic field reactivity
Implementation Method 2
allows for selective regulation of gene expression, reducing protein production by inhibiting RNA polymerase binding to DNA
Implementation Method 3
a silica coating layer coated on a surface of the polymer-iron oxide composite nanoparticle
Implementation Method 4
mixing a polymer and an iron oxide nanoparticle in an organic solvent, adding an aqueous solution of polyvinyl alcohol (PVA), stirring the same, and evaporating the organic solvent
Data Source
AI summary
The present disclosure relates to a polymer-iron oxide composite nanoparticle, a polymer-iron oxide composite nanoparticle including a silica coating layer coated on the surface of the polymer-iron oxide composite nanoparticle, a DNA-containing polymer-iron oxide composite nanostructure including DNA attached on the silica coating layer, a method of preparing the same and a method of controlling expression of a gene.